drugset / Trial / NCT00848302

Endothelial Function in Human Arteries

NCT00848302

Phase 0 Completed 25 enrolled The Cleveland Clinic
NaSingle-groupOpen-labelTreatment

Summary

Up to 30 patients with lower extremity disease scheduled to undergo diagnostic angiography will undergo baseline bloodwork and IVUS (intravascular ultrasound), followed by dosing with L-arginine to assess changes in endothelial function.

Timeline

Start
2009-09
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject L-arginine Small molecule 50 mg Other
Subject L-arginine Small molecule 100 mg Other
Subject L-arginine Small molecule 500 mg Other

Indications

No indication recorded.